Xconomy: A Look Ahead for Washington States Life Sciences Cluster
Summary
A Look Ahead for Washington State’s Life Sciences Cluster Opinion (Page 2 of 2) recovered, and that lack of economic recovery spills down to companies in both the public and private sectors—impacting their ability to obtain the funding they need to advance their technology and product development efforts.Today, we represent more than 450 member organizations and we span a broad range of companies and institutions, from the biopharmaceutical sector, to medical devices, to IT-based life sciences companies, to global health organizations, to research institutions, and a host of other entities that impact health care both in the creation of healthcare products and healthcare delivery here in the state.We will work hard to attract investors and companies (both public and private) to review and help increase the likelihood that our member organizations might receive the funding necessary to continue their research and product development efforts.This effort has already resulted in grants that will create local jobs and help several organizations to develop innovative global health products.I look forward to working closely with our members to support their efforts in translating innovation to realization, from breakthrough discoveries to better health solutions.